Gene expression of COX-2, MLH1 and MSH2 in papillary thyroid carcinoma: a retrospective analysis

被引:0
作者
Garcia-Torres, Edgar [1 ]
Zambrano-Galvan, Graciela [2 ]
Cuevas-Gonzalez, Juan Carlos [3 ]
Barajas Perez, Victor Hiram [1 ]
机构
[1] Juarez Univ State Durango, Fac Dent, Durango, Mexico
[2] Juarez Univ State Durango, Fac Med & Nutr, Nutriepigen & Clin Nutr Lab, Durango, Mexico
[3] Autonomous Univ Ciudad Juarez, Inst Biomed Sci, Dept Stomatol, Ciudad Juarez, Chihuahua, Mexico
来源
MEDICINA BALEAR | 2022年 / 37卷 / 05期
关键词
Papillary thyroid carcinoma; gene; expression; CANCER; ANGIOGENESIS; PATHOGENESIS; MECHANISMS; VARIANTS;
D O I
10.3306/AJHS.2022.37.05.111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objetives: To determine the mRNA expression of the COX-2, MLH1 and MSH2 genes in Papillary Thyroid Carcinoma. Methods: This is comparative cross-sectional clinical molecular study. The study was constituted by 26 biopsies with histopathological diagnosis of Papillary Thyroid Carcinoma, from the 450 General Hospital of Durango State. The relative gene expression of the COX-2, MLH1 and MSH2 was performed by qPCR. Results: The mean age of patients was 46 +/- 15.22. They were observed differences in the gene expression of COX-2 (p = 0.001), MLH1 (p = 0.06) and MSH2 (p = 0.09) in the total Papillary Thyroid Carcinoma sample. The correlation between gene expression and patient age was r(2) = 0.441 (p = 0.024) for the MSH2 gene. The correlation of mRNA expression between COX-2 and MLH1 was r(2) = 0.69 (p = 0.001); for COX-2 and MSH2 of r(2) = 0.47 (p = 0.01), while for MSH1 and MSH2 of r(2) = 0.94 (p = 0.001). Conclusions: The results obtained in the present study showing the presence of gene expression of molecular targets such as the COX-2, MLH1 and MSH2 genes, contributing to the understanding of the molecular physiopathology of the Papillary Thyroid Carcinoma.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 40 条
  • [1] The cyclooxygenases
    Chandrasekharan, NV
    Simmons, DL
    [J]. GENOME BIOLOGY, 2004, 5 (09)
  • [2] Chen H., 2012, NAJ MED SCI, V5, P212
  • [3] Cyclooxygenase-2 biology
    Clària, J
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (27) : 2177 - 2190
  • [4] Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry
    Cramer, John D.
    Fu, Pingfu
    Harth, Karem C.
    Margevicius, Seunghee
    Wilhelm, Scott M.
    [J]. SURGERY, 2010, 148 (06) : 1147 - 1152
  • [5] Duntas Leonidas, 2006, Hell J Nucl Med, V9, P156
  • [6] Figge JJ., 2016, Thyroid Cancer, P9, DOI [DOI 10.1007/978-1-4939-3314-32, DOI 10.1007/978-1-4939-3314-3_2]
  • [7] Variants of papillary thyroid carcinoma: association with histopathological prognostic factors
    Girardi, Fabio Muradas
    Barra, Marinez Bizarro
    Zettler, Claudio Galleano
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2013, 79 (06) : 738 - 744
  • [8] Thyroid Cancer: Current Molecular Perspectives
    Giusti, Francesca
    Falchetti, Alberto
    Franceschelli, Francesco
    Marini, Francesca
    Tanini, Annalisa
    Brandi, Maria Luisa
    [J]. JOURNAL OF ONCOLOGY, 2010, 2010
  • [9] Gonzalez H, 2006, B ESC MED, V31, P87
  • [10] Gonzalez-Gonzalez Rogelio, 2011, ISRN Oncol, V2011, P915925, DOI 10.5402/2011/915925